Figure 2.
MNX1 expression in pediatric AML with t(7;12)(q36;p13) translocation. (A-B) MNX1 expression in 2 different pediatric AML cohorts. (A) Balgobind et al31; 237 samples profiled with Affymetrix arrays. The mean expression level is shown with a dashed line, and the mean plus 3 standard deviations is shown with a horizontal line. (B) TARGET-AML29; 1319 samples profiled with RNAseq (cutoff, 0.5 TPM). Samples with cytogenetically detected t(7;12)(q36;p13) translocation are shown in green and other samples in gray. exp, expression; TPM, transcripts per million.

MNX1 expression in pediatric AML with t(7;12)(q36;p13) translocation. (A-B) MNX1 expression in 2 different pediatric AML cohorts. (A) Balgobind et al31; 237 samples profiled with Affymetrix arrays. The mean expression level is shown with a dashed line, and the mean plus 3 standard deviations is shown with a horizontal line. (B) TARGET-AML29; 1319 samples profiled with RNAseq (cutoff, 0.5 TPM). Samples with cytogenetically detected t(7;12)(q36;p13) translocation are shown in green and other samples in gray. exp, expression; TPM, transcripts per million.

Close Modal

or Create an Account

Close Modal
Close Modal